Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin and Trust in Animal-Assisted Interventions
NCT06248710Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in major depressive disorder (MDD). Started Jan 2024; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06248710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06248710.